Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Dubovsky

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
The Journal of Clinical Investigation|October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host diseaseJason A Dubovsky, Ryan Flynn, Jing Du, et al.
Blood|July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesJason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
The Journal of Clinical Investigation|October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host diseaseJason A Dubovsky, Ryan Flynn, Jing Du, et al.
Blood|July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesJason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
Pageof 3